risedronic acid has been researched along with Anorexia Nervosa in 3 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Anorexia Nervosa: An eating disorder that is characterized by the lack or loss of APPETITE, known as ANOREXIA. Other features include excess fear of becoming OVERWEIGHT; BODY IMAGE disturbance; significant WEIGHT LOSS; refusal to maintain minimal normal weight; and AMENORRHEA. This disorder occurs most frequently in adolescent females. (APA, Thesaurus of Psychological Index Terms, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Anorexia nervosa is complicated by low bone mineral density (BMD) and increased fracture risk associated with low bone formation and high bone resorption." | 3.01 | Sequential Therapy With Recombinant Human IGF-1 Followed by Risedronate Increases Spine Bone Mineral Density in Women With Anorexia Nervosa: A Randomized, Placebo-Controlled Trial. ( Bachmann, KN; Bredella, MA; Ciotti, L; Dechant, E; Ebrahimi, S; Eddy, KT; Gleysteen, S; Gupta, R; Haines, MS; Keane, RJ; Kimball, A; Klibanski, A; Meenaghan, E; Mickley, D; Miller, KK; Misra, M; Santoso, K; Schoenfeld, D; Singhal, V; Tan, CO; Weigel, T, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Haines, MS | 1 |
| Kimball, A | 1 |
| Meenaghan, E | 2 |
| Bachmann, KN | 1 |
| Santoso, K | 1 |
| Eddy, KT | 1 |
| Singhal, V | 1 |
| Ebrahimi, S | 1 |
| Dechant, E | 1 |
| Weigel, T | 1 |
| Ciotti, L | 1 |
| Keane, RJ | 1 |
| Gleysteen, S | 2 |
| Mickley, D | 2 |
| Bredella, MA | 1 |
| Tan, CO | 1 |
| Gupta, R | 1 |
| Misra, M | 2 |
| Schoenfeld, D | 2 |
| Klibanski, A | 3 |
| Miller, KK | 3 |
| Lawson, EA | 1 |
| Herzog, D | 1 |
| Grieco, KA | 1 |
| Mulder, J | 1 |
| Grinspoon, S | 1 |
| Yehezkel, R | 1 |
| Herzog, DB | 1 |
3 trials available for risedronic acid and Anorexia Nervosa
| Article | Year |
|---|---|
Sequential Therapy With Recombinant Human IGF-1 Followed by Risedronate Increases Spine Bone Mineral Density in Women With Anorexia Nervosa: A Randomized, Placebo-Controlled Trial.
Topics: Absorptiometry, Photon; Anorexia Nervosa; Bone Density; Female; Humans; Insulin-Like Growth Factor I | 2021 |
Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study.
Topics: Administration, Cutaneous; Adult; Androgens; Anorexia Nervosa; Bone Density; Bone Density Conservati | 2011 |
Effects of risedronate on bone density in anorexia nervosa.
Topics: Adult; Anorexia Nervosa; Biomarkers; Bone and Bones; Bone Density; Etidronic Acid; Female; Humans; P | 2004 |